Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision | ||
nshd:dsctte [20/03/2018 @ 09:49] – adammoore | nshd:dsctte [20/03/2018 @ 09:56] – [NSHD Data Sharing Committee] adammoore | ||
---|---|---|---|
Line 15: | Line 15: | ||
- | Researchers are encouraged to view the list of previously approved data sharing proposals | + | Researchers are encouraged to view the [[approved|list of previously approved data sharing proposals]] |
to assess points of similarity or overlap with already existing projects. | to assess points of similarity or overlap with already existing projects. | ||
Line 22: | Line 22: | ||
may be subject to a charge to cover the additional costs incurred by the LHA. Any such | may be subject to a charge to cover the additional costs incurred by the LHA. Any such | ||
costs will be notified in advance. | costs will be notified in advance. | ||
+ | \\ \\ | ||
- | ==== Correspondence and timings for review of submissions | + | === Correspondence and timings for review of submissions === |
Receipt of your application will be notified using the email address you supplied. If you have | Receipt of your application will be notified using the email address you supplied. If you have | ||
not received an electronic confirmation of your submission within 10 working days please | not received an electronic confirmation of your submission within 10 working days please | ||
- | contact swiftinfo@nshd.mrc.ac.uk. | + | contact |
The LHA/NSHD Data Sharing Committee meets once a month to assess all new applications | The LHA/NSHD Data Sharing Committee meets once a month to assess all new applications | ||
Line 33: | Line 34: | ||
upon the timing of the original proposal in relation to the meetings. Applicants will be | upon the timing of the original proposal in relation to the meetings. Applicants will be | ||
notified by email if their application to use the data will be delayed beyond these time lines. | notified by email if their application to use the data will be delayed beyond these time lines. | ||
+ | \\ \\ | ||
=== Rejected proposals and appeals procedure === | === Rejected proposals and appeals procedure === | ||
Line 44: | Line 46: | ||
may involve additional conditions for use of the data: this list is indicative rather than | may involve additional conditions for use of the data: this list is indicative rather than | ||
exhaustive. | exhaustive. | ||
- | * Proposals that require access to a specialist database created by a key collaborator or have required significant investments in time by the study team. | + | * Proposals that require access to a specialist database created by a key collaborator or have required significant investments in time by the study team |
- | * Proposals that require access to sensitive data. Sensitive data include, but are not limited to, the cause and date of death of a study member, data on residential or emigration history, and medical and other information with small cell counts (e.g. some ICD hospital admissions, or childhood enuresis variables). | + | * Proposals that require access to sensitive data. Sensitive data include, but are not limited to, the cause and date of death of a study member, data on residential or emigration history, and medical and other information with small cell counts (e.g. some ICD hospital admissions, or childhood enuresis variables) |
- | * Proposals requiring access to data or meta-data that have not yet been through vigorous quality assurances protocols in place and will require a significant amount of time to check and/or clean. | + | * Proposals requiring access to data or meta-data that have not yet been through vigorous quality assurances protocols in place and will require a significant amount of time to check and/or clean |
- | * Proposals requiring access to extensive biomedical data or that significantly overlap with the current scientific programmes of the NSHD study team. | + | * Proposals requiring access to extensive biomedical data or that significantly overlap with the current scientific programmes of the NSHD study team |
- | * Proposals from researchers outside the UK. | + | * Proposals from researchers outside the UK |